This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

UPC Court of Appeal reverses Milan decision in Insulet v EOFlow dispute

By Inbar Preiss ( May 5, 2025, 14:06 GMT | Insight) -- Insulet Corporation secured a preliminary injunction that reverses a prior lower court denial in a dispute over its insulin patch pump patent. The injunction bans EOFlow from manufacturing, marketing, or distributing the infringing insulin pump devices using this patent across 17 UPC member states pending a final ruling expected around December. The decision was founded on strict claim construction, a demonstrated likelihood of infringement, and the risk of continued market disruption.The Court of Appeal of the Unified Patent Court granted a preliminary injunction in favor of US-based Insulet Corporation, reversing an earlier denial by the Milan Central Division....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections